Variant report

Variant	esv1795417
Chromosome Location	chr12:32635183-32648257
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr12:32635142-32635540	GM12878	blood:	n/a	n/a
2	CHD1	chr12:32635373-32635526	GM12878	blood:	n/a	n/a
3	CTCF	chr12:32636760-32636910	GM12875	blood:	n/a	n/a
4	CTCF	chr12:32636602-32636668	Kidney_OC	kidney:	n/a	n/a
5	CTCF	chr12:32636460-32636610	HCPEpiC	choroid plexus:	n/a	n/a
6	CTCF	chr12:32635500-32635650	HPAF	blood vessel:	n/a	n/a
7	CUX1	chr12:32635448-32635456	GM12878	blood:	n/a	n/a
8	E2F4	chr12:32638531-32639342	MCF10A-Er-Src	breast:	n/a	n/a
9	E2F4	chr12:32646552-32646752	MCF10A-Er-Src	breast:	n/a	n/a
10	ELF1	chr12:32636566-32636748	K562	blood:	n/a	chr12:32636679-32636692
11	ELK1	chr12:32635706-32635775	GM12878	blood:	n/a	n/a
12	EP300	chr12:32635227-32635372	GM12878	blood:	n/a	chr12:32635335-32635344
13	ESR1	chr12:32646187-32646596	ECC-1	luminal epithelium:	n/a	n/a
14	FOS	chr12:32647785-32647830	MCF10A-Er-Src	breast:	n/a	n/a
15	FOS	chr12:32639229-32639453	MCF10A-Er-Src	breast:	n/a	n/a
16	FOS	chr12:32638667-32639517	MCF10A-Er-Src	breast:	n/a	n/a
17	FOS	chr12:32638674-32639518	MCF10A-Er-Src	breast:	n/a	n/a
18	FOS	chr12:32638672-32638999	MCF10A-Er-Src	breast:	n/a	n/a
19	FOS	chr12:32638674-32639012	MCF10A-Er-Src	breast:	n/a	n/a
20	FOS	chr12:32638872-32639625	HUVEC	blood vessel:	n/a	n/a
21	FOXA1	chr12:32639238-32639445	A549	lung:	n/a	n/a
22	GATA2	chr12:32639017-32639644	HUVEC	blood vessel:	n/a	chr12:32639290-32639307 chr12:32639282-32639303 chr12:32639289-32639296 chr12:32639288-32639298 chr12:32639289-32639296 chr12:32639289-32639296 chr12:32639284-32639298
23	GATA3	chr12:32639145-32639435	T-47D	breast:	n/a	chr12:32639290-32639307 chr12:32639282-32639303 chr12:32639289-32639296 chr12:32639288-32639298 chr12:32639289-32639296 chr12:32639289-32639296
24	GATA3	chr12:32639215-32639330	SH-SY5Y	brain:	n/a	chr12:32639290-32639307 chr12:32639282-32639303 chr12:32639289-32639296 chr12:32639288-32639298 chr12:32639289-32639296 chr12:32639289-32639296
25	JUN	chr12:32639039-32639583	HUVEC	blood vessel:	n/a	n/a
26	JUN	chr12:32644190-32644322	H1-hESC	embryonic stem cell:	n/a	n/a
27	JUND	chr12:32639047-32639259	HepG2	liver:	n/a	n/a
28	MAFF	chr12:32636522-32636780	K562	blood:	n/a	n/a
29	MAFF	chr12:32636460-32636815	HepG2	liver:	n/a	n/a
30	MAFK	chr12:32636544-32636780	Hela-S3	cervix:	n/a	chr12:32636626-32636637 chr12:32636626-32636641 chr12:32636627-32636638 chr12:32636626-32636642 chr12:32636627-32636638 chr12:32636625-32636639 chr12:32636626-32636637 chr12:32636629-32636646
31	MAFK	chr12:32636473-32636787	IMR90	lung:	n/a	chr12:32636626-32636637 chr12:32636626-32636641 chr12:32636627-32636638 chr12:32636626-32636642 chr12:32636627-32636638 chr12:32636625-32636639 chr12:32636626-32636637 chr12:32636629-32636646
32	MAFK	chr12:32636456-32636811	HepG2	liver:	n/a	chr12:32636626-32636637 chr12:32636626-32636641 chr12:32636627-32636638 chr12:32636626-32636642 chr12:32636627-32636638 chr12:32636625-32636639 chr12:32636626-32636637 chr12:32636629-32636646
33	MAFK	chr12:32636451-32636809	HepG2	liver:	n/a	chr12:32636626-32636637 chr12:32636626-32636641 chr12:32636627-32636638 chr12:32636626-32636642 chr12:32636627-32636638 chr12:32636625-32636639 chr12:32636626-32636637 chr12:32636629-32636646
34	MAFK	chr12:32636503-32636730	K562	blood:	n/a	chr12:32636626-32636637 chr12:32636626-32636641 chr12:32636627-32636638 chr12:32636626-32636642 chr12:32636627-32636638 chr12:32636625-32636639 chr12:32636626-32636637 chr12:32636629-32636646
35	MAX	chr12:32638708-32638976	NB4	blood:	n/a	n/a
36	MAX	chr12:32634938-32635763	NB4	blood:	n/a	n/a
37	MEF2A	chr12:32635101-32635655	GM12878	blood:	n/a	chr12:32635525-32635541 chr12:32635524-32635540 chr12:32635101-32635109 chr12:32635374-32635388
38	MEF2A	chr12:32635183-32635634	GM12878	blood:	n/a	chr12:32635525-32635541 chr12:32635524-32635540 chr12:32635374-32635388
39	MEF2C	chr12:32635208-32635533	GM12878	blood:	n/a	chr12:32635374-32635389 chr12:32635374-32635388
40	MYC	chr12:32635169-32635565	NB4	blood:	n/a	n/a
41	MYC	chr12:32638678-32639445	MCF10A-Er-Src	breast:	n/a	n/a
42	MYC	chr12:32635384-32635439	K562	blood:	n/a	n/a
43	MYC	chr12:32638581-32638983	MCF10A-Er-Src	breast:	n/a	n/a
44	MYC	chr12:32638739-32638991	NB4	blood:	n/a	n/a
45	NFYB	chr12:32635117-32635464	GM12878	blood:	n/a	n/a
46	NR3C1	chr12:32639194-32639497	A549	lung:	n/a	chr12:32639349-32639367
47	NR3C1	chr12:32639205-32639417	A549	lung:	n/a	chr12:32639349-32639367
48	NR3C1	chr12:32639155-32639458	A549	lung:	n/a	chr12:32639349-32639367
49	NR3C1	chr12:32639197-32639460	A549	lung:	n/a	chr12:32639349-32639367
50	NR3C1	chr12:32638614-32639010	A549	lung:	n/a	n/a

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-BICD1-3	chr12:32641924-32642537	NONHSAT027612
2	lnc-BICD1-3	chr12:32638906-32639079	NONHSAT027612
3	lnc-BICD1-3	chr12:32643024-32644081	NONHSAT027612

Variant related genes	Relation type
FGD4	TF binding region
RNU6-494P	TF binding region

Extended variants
information (count: 430 )
Associated
traits (count: 58 )

Variant overlapped rSNPs/rCNVs (count:430 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7961107	chr12:32635183-32635184	Weak transcription Strong transcription Enhancers Flanking Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs7961486	chr12:32635237-32635238	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs145418628	chr12:32635279-32635280	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
4	rs34763149	chr12:32635293-32635294	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
5	rs188191010	chr12:32635350-32635351	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
6	rs565858627	chr12:32635379-32635380	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
7	rs546445730	chr12:32635386-32635387	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
8	rs147700878	chr12:32635390-32635391	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
9	rs527432878	chr12:32635434-32635435	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs547426723	chr12:32635437-32635438	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs118189277	chr12:32635475-32635476	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs149081498	chr12:32635504-32635505	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs549679565	chr12:32635505-32635506	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs182063820	chr12:32635554-32635555	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs570353005	chr12:32635704-32635705	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs117040235	chr12:32635738-32635739	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs186402647	chr12:32635741-32635742	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs565859250	chr12:32635744-32635745	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs534819066	chr12:32635800-32635801	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs7296494	chr12:32635814-32635815	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs116207665	chr12:32635856-32635857	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs190863779	chr12:32635860-32635861	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs557379810	chr12:32635882-32635883	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs577656181	chr12:32635971-32635972	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs183437536	chr12:32636013-32636014	Weak transcription Enhancers Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs7312690	chr12:32636014-32636015	Weak transcription Enhancers Strong transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs142188708	chr12:32636056-32636057	Weak transcription Enhancers Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs540790547	chr12:32636058-32636059	Weak transcription Enhancers Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs35398012	chr12:32636072-32636073	Weak transcription Enhancers Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs7299495	chr12:32636076-32636077	Weak transcription Enhancers Strong transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs529724772	chr12:32636158-32636159	Weak transcription Enhancers Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs543745771	chr12:32636203-32636204	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs562941770	chr12:32636216-32636217	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs375018401	chr12:32636245-32636246	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs532313936	chr12:32636314-32636315	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs369026179	chr12:32636345-32636346	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs151221328	chr12:32636370-32636371	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs373453054	chr12:32636384-32636385	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs565741050	chr12:32636414-32636415	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs528263673	chr12:32636424-32636425	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs561825881	chr12:32636428-32636429	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs10844216	chr12:32636429-32636430	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs35048543	chr12:32636454-32636455	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs537535786	chr12:32636499-32636500	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs557430191	chr12:32636525-32636526	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs570816752	chr12:32636562-32636563	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs186852527	chr12:32636570-32636571	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs553601110	chr12:32636571-32636572	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs573371722	chr12:32636584-32636585	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs140355810	chr12:32636658-32636659	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:58)

Disease	PMID	Source
Myxofibrosarcoma	16751306	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Acute myeloid leukemia	16864856	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Ewing''s sarcoma	17952124	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21858162	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Cancer	20164919	CNVD
Neurodevelopmental disorder	22521361	CNVD
Breast cancer	21509527	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Cancer	21129771	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17899364	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Breast cancer	17133270	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Myelofibrosis	22110671	CNVD
microdeletion syndrome	16199537	CNVD
Chordoma	18071362	CNVD
Ovarian cancer	21720365	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Ovarian cancer	21781307	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:430 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:32594600-32659000	Weak transcription	Esophagus	oesophagus
2	chr12:32602600-32636400	Weak transcription	Sigmoid Colon	Sigmoid Colon
3	chr12:32610800-32636400	Weak transcription	NHEK	skin
4	chr12:32610800-32639000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
5	chr12:32616000-32638600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
6	chr12:32619600-32642000	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
7	chr12:32621600-32636400	Weak transcription	Right Ventricle	heart
8	chr12:32621800-32654000	Weak transcription	Lung	lung
9	chr12:32624800-32636400	Weak transcription	HMEC	breast
10	chr12:32625000-32636400	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
11	chr12:32625000-32655800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
12	chr12:32625200-32636400	Weak transcription	Gastric	stomach
13	chr12:32625200-32655200	Weak transcription	H9 Cell Line	embryonic stem cell
14	chr12:32627200-32638600	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
15	chr12:32628600-32637200	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
16	chr12:32629400-32643600	Weak transcription	Cortex derived primary cultured neurospheres	brain
17	chr12:32629600-32635400	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
18	chr12:32629600-32643000	Weak transcription	HUES64 Cell Line	embryonic stem cell
19	chr12:32629800-32636000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
20	chr12:32629800-32636400	Weak transcription	HUES6 Cell Line	embryonic stem cell
21	chr12:32629800-32636400	Weak transcription	Fetal Muscle Leg	muscle
22	chr12:32629800-32636400	Weak transcription	Left Ventricle	heart
23	chr12:32630000-32638800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
24	chr12:32630600-32636200	Weak transcription	Fetal Brain Male	brain
25	chr12:32630800-32638000	Weak transcription	iPS-15b Cell Line	embryonic stem cell
26	chr12:32631400-32636600	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
27	chr12:32631600-32636200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
28	chr12:32631600-32638800	Enhancers	Primary monocytes fromperipheralblood	blood
29	chr12:32631800-32636600	Weak transcription	Small Intestine	intestine
30	chr12:32631800-32643600	Weak transcription	HUES48 Cell Line	embryonic stem cell
31	chr12:32632000-32635200	Weak transcription	Skeletal Muscle Female	skeletal muscle
32	chr12:32632000-32635200	Weak transcription	HSMM	muscle
33	chr12:32632000-32635200	Weak transcription	HSMMtube	muscle
34	chr12:32632000-32643600	Weak transcription	H1 Cell Line	embryonic stem cell
35	chr12:32632200-32635200	Weak transcription	Pancreatic Islets	Pancreatic Islet
36	chr12:32632400-32635200	Weak transcription	Rectal Mucosa Donor 29	rectum
37	chr12:32632400-32636200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
38	chr12:32632400-32636200	Weak transcription	Rectal Mucosa Donor 31	rectum
39	chr12:32632400-32636400	Weak transcription	Muscle Satellite Cultured Cells	--
40	chr12:32632400-32636400	Weak transcription	A549	lung
41	chr12:32633000-32636200	Weak transcription	Stomach Mucosa	stomach
42	chr12:32633200-32638600	Weak transcription	Fetal Intestine Large	intestine
43	chr12:32633800-32637600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
44	chr12:32634000-32655000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
45	chr12:32634200-32638200	Enhancers	Primary neutrophils fromperipheralblood	blood
46	chr12:32634400-32635200	Enhancers	Primary B cells from cord blood	blood
47	chr12:32634400-32635600	Enhancers	Primary hematopoietic stem cells short term culture	blood
48	chr12:32634400-32636800	Enhancers	Primary B cells from peripheral blood	blood
49	chr12:32634400-32638600	Enhancers	HUVEC	blood vessel
50	chr12:32634600-32635800	Weak transcription	Fetal Intestine Small	intestine

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links